Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose
Clinical trial NCT05809271 · COMPLETED
Trial details
- NCT number
- NCT05809271
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2025-03-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.